GeneScience

At GeneScience we study the genomes of patients with different types of cancer, with the aim of discovering DNA mutations that help select drug therapies directed against cancer cells. This personalized approach not only allows us to identify specific genetic alterations that could be driving the development of cancer in each individual, but also facilitates the creation of more effective treatments that are aimed at destroying only cancer cells without harming healthy cells in patients. Through cutting-edge technology, such as next-generation sequencing (NGS), bioinformatics analysis, and a multidisciplinary team of experts in genetics, oncology, and pharmacology, we seek to better understand the complexity of cancer, thus optimizing treatment protocols and improving the quality of life of our patients. With genome studies, our goal is to significantly contribute to the advancement of precision medicine in the oncology field. In addition, we collaborate with research institutions and hospitals to stay at the forefront of scientific and technological advances that allow us to innovate in the treatment and monitoring strategies of our patients.